Edition:
India

Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Capital Market

3.12USD
17 May 2019
Change (% chg)

$-0.14 (-4.29%)
Prev Close
$3.26
Open
$3.23
Day's High
$3.29
Day's Low
$3.08
Volume
53,459
Avg. Vol
95,241
52-wk High
$11.55
52-wk Low
$2.74

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 1.42 -1.402
FY 2018 Dec '18 1.76 -0.808
Sep '18 0.94 -0.664
Jun '18 2.76 -1.669
Mar '18 4.07 -12.607
FY 2017 Dec '17 3.46 -2.519
Sep '17 3.92 -3.050
Jun '17 3.83 -3.422
Mar '17 1.53 -4.190
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 1 1.26 1.26 1.26 --
Quarter Ending Sep-19 1 1.26 1.26 1.26 --
Year Ending Dec-19 1 5.10 5.10 5.10 7.38
Year Ending Dec-20 1 6.00 6.00 6.00 8.10
Earnings (per share)
Quarter Ending Jun-19 1 -1.13 -1.13 -1.13 --
Quarter Ending Sep-19 1 -1.18 -1.18 -1.18 --
Year Ending Dec-19 1 -4.80 -4.80 -4.80 -10.41
Year Ending Dec-20 1 -3.69 -3.69 -3.69 -10.65
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 23.83 18.18 -6.04
EPS (TTM) % 3.41 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Celldex Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 26.02%
# of Holders: 64
Total Shares Held: 3,582,251
3 Mo. Net Change: 62,431
# New Positions: 12
# Closed Positions: 38
# Increased Positions: 32
# Reduced Positions: 52
# Net Buyers: -20
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.